학술논문

Linac-based radiosurgery or hypofractionated stereotactic radiotherapy in the treatment of large cerebral arteriovenous malformations
Document Type
Report
Source
International Journal of Radiation Oncology, Biology, Physics. March 15, 2006, Vol. 64 Issue 4, p1049, 6 p.
Subject
Radiotherapy -- Analysis
Arteriovenous malformations -- Care and treatment
Arteriovenous malformations -- Analysis
Oncology, Experimental -- Analysis
Surgery -- Analysis
Cancer -- Research
Cancer -- Analysis
Language
English
ISSN
0360-3016
Abstract
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ijrobp.2005.09.021 Byline: Angelika Zabel-du Bois ([cor])(a ), Stefanie Milker-Zabel ([cor]), Peter Huber (a ), Wolfgang Schlegel (a ), Jurgen Debus ([cor]) Keywords: Radiotherapy; Radiosurgery; Hypofractionated; AVM; Obliteration rate Abstract: Purpose: We investigate retrospectively clinical outcome after radiosurgery (RS) or hypofractionated stereotactic radiotherapy (HSRT) in patients with large cerebral arteriovenous malformations (AVMs). Methods and Materials: This analysis is based on 48 patients with cerebral AVM greater than 4 cm treated with HSRT or RS at our institution. Fifteen patients received HSRT, with 26 Gy median total dose in 4 to 5 fractions, and 33 patients received RS with 17 Gy median total dose in 4 to 5 fractions. Median target volume was 27 cc in HSRT and 7 cc in RS; median maximum diameter was 6 cm and 5 cm, respectively. Seventeen patients experienced intracranial hemorrhage before treatment. Median follow-up was 2.6 years. Results: The 3-year and 4-year actuarial complete obliteration (CO) after HSRT was 17% and 33% and after RS was 47% and 60%, respectively. Actuarial CO was higher in AVMs less than 5 cm (66% vs. 37% after 4 years). Intracranial hemorrhage after HSRT occurred in 3 of 15 patients after 18 months median, and after RS in 7 of 33 patients after 17 months median. Bleeding risk was significantly higher in patients with prior hemorrhage (p < 0.04). Preexisting neurologic dysfunction improved/dissolved in 50% and remained stable in 45%. Conclusions: Large AVMs need a long time period to obliterate and show a high bleeding risk. Multimodal treatment strategies are required to reduce treatment volume before radiotherapy. Author Affiliation: ([cor]) Department of Radiooncology, University of Heidelberg, Heidelberg, Germany (a ) Department of Radiotherapy, German Cancer Research Center, Heidelberg, Germany (a ) Department of Medical Physics, German Cancer Research Center, Heidelberg, Germany Article History: Received 23 June 2005; Revised 26 August 2005; Accepted 26 September 2005